This BCG discussion is boring. I would give you credit if you can enlighten me what the replacement could be. I doubt you can.
SII in India makes 70% of the world supply. In UK, the approved BCG vaccine is from AJ Vaccines in Denmark. There are 20+ other vendors if you want to loom around.
Dendreon's pulsing technology cannot make DCs load as many as tumor-associated antigens as NWBO's. It's just that simple.
Absolutely true. But which is better? You do understand there is a reason why some doubt the ATL concept is that exposing too many antigens causes the T cells to be less effective at attacking the actual targets and more specific targeting is better? You did post a video stating this.
Not saying the single (or several) antigen method is the way to go, as cancers can mutate around. But the idea it is clear is simply wrong.